New tool aims to curb overtreatment of Low-Risk thyroid cancer
NCT ID NCT06073223
First seen Nov 19, 2025 · Last updated May 14, 2026 · Updated 18 times
Summary
This pilot study tested a tool called CQUPLE to help 50 patients newly diagnosed with low-risk thyroid cancer make informed treatment choices. Participants were randomly assigned to receive the tool or usual care before their surgeon visit. The study measured how acceptable and feasible the tool was, and whether it affected treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Michigan Cancer Center
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.